TP53 and neoplasm: Under conditions of FTD-induced DNA replication stress, tumor cells expressing wild-type p53 exhibit p53–p21 pathway activation, cyclin B1 degradation during the G2 phase, mitotic skipping, and subsequently cellular senescence.